The Health Insurance Organisation (HIO) informs the beneficiaries of the Health Insurance Scheme that the prescription criteria for the following pharmaceutical products have been extended.
These are:
- Xarelto
- Eliquis
- Pradaxa
As a result, a greater number of beneficiaries will be able to receive the above pharmaceutical products through the SHI.
"Beneficiaries affected by this decision are requested to contact their treating physician to find out whether they meet the new criteria put in place by the Agency," the OAS says.
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source
